Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis.

Purpose: The coronavirus disease 2019 (COVID-19) pandemic has shown unprecedented impact world-wide since the eruption in late 2019. Importantly, emerging reports suggest an increased risk of thromboembolism development in patients with COVID-19. Meanwhile, it is found that aspirin reduced mortality...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Clinical Pharmacology Vol. 78; no. 9; pp. 1403 - 1421
Autores principales: Ma, Shaodi, Su, Wanying, Sun, Chenyu, Lowe, Scott, Zhou, Zhen, Liu, Haixia, Qu, Guangbo, Xia, Weihang, Xie, Peng, Wu, Birong, Gao, Juan, Feng, Linya, Sun, Yehuan
Formato: meta analysis research tables/charts Journal Article
Publicado: Springer Nature Sep2022
Acceso en línea:Ver este registro en EBSCOhost